1. 1) Fletcher CD, Unni KK, Mertens F, editors. World Health Organization Classification of Tumours: Tumours of Soft Tissue and Bone. Lyon: IARC Press; 2002. p. 120–122.
2. 2) Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F, editors. WHO Classification of Tumours of Soft Tissue and Bone. Lyon: IARC Press; 2013. p. 236–238.
3. 4) Weiss SW, Goldblum JR. Malignant fibrous histiocytoma (pleomorphic undifferentiated sarcoma). In: Weiss SW, Goldblum JR, editors. Enzinger and Weiss’s Soft Tissue Tumors. 5th ed. St. Louis, Mo: Mosby; 2008. p. 403–427.
4. 5) Soft Tissue Sarcoma [Internet]. Fort Washington (USA): National Comprehensive Cancer Network (NCCN); 2014. NCCN Guide lines for Patients. Soft Tissue Sarcoma. Version 1. Available from: http://www.nccn.org/patients/guidelines/sarcoma/files/assets/common/downloads/files/sarcoma.pdf#search=‘NCCN+Guide+lines+for+Patients.Version+1.2014.Soft+Tissue+Sarcoma’
5. 6) Leite C, Goodwin JW, Sinkovics FG, Baker LH, Benjamen R. Chemotherapy of malignant fibrous histiocytoma. A southwest oncology group report. Cancer. 1977;40:2010–2014.